Text

70 Years of Levothyroxine

---

This open access book presents the history, pharmacokinetics and pharmacodynamics of levothyroxine, discussing its role in the thyroid pathophysiology of patients of various ages and during pregnancy. It also describes the influence of levothyroxine on heart, bone and in cancer.
When it was first synthesized in 1949, levothyroxine represented a significant advance in the treatment of hypothyroidism, providing a safe and effective treatment option for millions of hypothyroid patients around the globe. This synthetic form of thyroxine is now one of the most prescribed drugs in the world. Levothyroxine was first introduced by Merck KGaA,Darmstadt, Germany, in 1972, and since then the company has remained actively engaged in research on this mainstay of hypothyroidism treatment.
This book is intended for healthcare professionals.

---

Availability

No copy data

Detail Information

Series Title

-

Call Number

-

Publisher

Cham : Springer Cham., 2021

Collation

-

Language

English

ISBN/ISSN

978-3-030-63277-9

Classification

NONE

Content Type

text

Media Type

computer

Carrier Type

online resource

Edition

-

Subject(s)

Medicine

Specific Detail Info

-

Statement of Responsibility

George J. Kahaly

Other Information

Cataloger

Kholif Basri

Source

-

Validator

-

Digital Object Identifier (DOI)

https://doi.org/10.1007/978-3-030-63277-9

Journal Volume

-

Journal Issue

-

Subtitle

-

Parallel Title

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment